Immunological Predictors of Dimethyl Fumarate‐Induced Lymphopenia

Treatment with dimethyl fumarate (DMF) leads to lymphopenia and infectious complications in a subset of patients with multiple sclerosis (MS). Here, we aimed to reveal immune markers of DMF‐associated lymphopenia. This prospective observational study longitudinally assessed 31 individuals with MS by...

Descripción completa

Detalles Bibliográficos
Autores principales: Diebold, Martin, Galli, Edoardo, Kopf, Andreas, Sanderson, Nicholas, Callegari, Ilaria, Ingelfinger, Florian, Núñez, Nicolás Gonzalo, Benkert, Pascal, Kappos, Ludwig, Kuhle, Jens, Becher, Burkhard, Claassen, Manfred, Derfuss, Tobias
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Inc. 2022
Materias:
Brief Communications
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9314128/
https://www.ncbi.nlm.nih.gov/pubmed/35170072
http://dx.doi.org/10.1002/ana.26328

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9314128/
https://www.ncbi.nlm.nih.gov/pubmed/35170072
http://dx.doi.org/10.1002/ana.26328

Ejemplares similares